https://www.selleckchem.com/products/ots514.html
We investigated the synergistic effect between vancomycin and ß-lactams against vancomycin-susceptible (VSSA) and non-susceptible MRSA isolates (heterogeneous vancomycin-intermediate S. aureus (hVISA) and VISA). A total of 29 MRSA including 6 VISA, 14 hVISA and 9 VSSA isolates were subjected to a microbroth dilution-minimum inhibitory concentration (MIC) checkerboard using vancomycin combined with cefotaxime, imipenem or meropenem. To confirm synergistic activity, the representative strains of VISA, hVISA and VSSA were then selected for
Like
Comment
Share
